| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | KIN001-266 | GDSC1000 | pan-cancer | AAC | 0.0014 | 1 |
| mRNA | BRD-K70511574 | CTRPv2 | pan-cancer | AAC | 0.0011 | 1 |
| mRNA | erlotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0013 | 1 |
| mRNA | NVP-BEZ235 | CTRPv2 | pan-cancer | AAC | 0.0013 | 1 |
| mRNA | BRD-K75293299 | CTRPv2 | pan-cancer | AAC | -0.0019 | 1 |
| mRNA | ML203 | CTRPv2 | pan-cancer | AAC | 0.00094 | 1 |
| mRNA | apicidin | CTRPv2 | pan-cancer | AAC | 0.00077 | 1 |
| mRNA | SNS-032 | CTRPv2 | pan-cancer | AAC | 0.00085 | 1 |
| mRNA | ceranib-2 | CTRPv2 | pan-cancer | AAC | -0.0007 | 1 |
| mRNA | Bosutinib | CTRPv2 | pan-cancer | AAC | 0.0007 | 1 |